- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Medicamen Biotech Limited — Board Meeting, 27-05-2026: Outcome of Board Meeting
27-05-2026 | 03:44 pm
27-05-2026 | 03:44 pm
MEDICAMEN Biotech's board approved FY26 consolidated results: Net Profit at Rs 9.80 Cr and Revenue at Rs 200.88 Cr. A final dividend of Re 1.00 per share was proposed, pending shareholder nod.
No comments yet. Be the first to comment!